Preliminary results of PROCLAIM-CX-072: The first-in-human, dose-finding trial of PD-L1 probody therapeutic CX-072 as monotherapy in patients (pts) with advanced solid tumors Meeting Abstract


Authors: Boni, V.; Garcia-Corbacho, J.; Ott, P. A.; Cho, D. C.; Autio, K. A.; Uboha, N.; Spira, A. I.; Humphrey, R.; Will, M.; Naing, A.; Thistlethwaite, F.; de Vries, E. G. E.; Arkenau, H. T.
Abstract Title: Preliminary results of PROCLAIM-CX-072: The first-in-human, dose-finding trial of PD-L1 probody therapeutic CX-072 as monotherapy in patients (pts) with advanced solid tumors
Meeting Title: 43rd ESMO Congress (ESMO 2018)
Journal Title: Annals of Oncology
Volume: 29
Issue: Suppl. 8
Meeting Dates: 2018 Oct 19-23
Meeting Location: Munich, Germany
ISSN: 0923-7534
Publisher: Oxford University Press  
Date Published: 2018-10-01
Start Page: mdy279.422
Language: English
ACCESSION: WOS:000459277301019
PROVIDER: wos
DOI: 10.1093/annonc/mdy279.422
Notes: Meeting Abstract: 435P -- Appears on pages viii142-viii143 of the abstract book -- Source: Wos
Altmetric
Citation Impact
BMJ Impact Analytics
MSK Authors
  1. Karen Anne Autio
    119 Autio